Dian Diagnostics Group Statistics
Total Valuation
SHE:300244 has a market cap or net worth of CNY 11.54 billion. The enterprise value is 14.03 billion.
| Market Cap | 11.54B |
| Enterprise Value | 14.03B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | Jun 25, 2026 |
Share Statistics
SHE:300244 has 611.10 million shares outstanding. The number of shares has decreased by -0.39% in one year.
| Current Share Class | 611.10M |
| Shares Outstanding | 611.10M |
| Shares Change (YoY) | -0.39% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 28.40% |
| Owned by Institutions (%) | 16.58% |
| Float | 426.91M |
Valuation Ratios
The trailing PE ratio is 89.20 and the forward PE ratio is 28.29.
| PE Ratio | 89.20 |
| Forward PE | 28.29 |
| PS Ratio | 1.16 |
| PB Ratio | 1.33 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | 6.47 |
| P/OCF Ratio | 5.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.44, with an EV/FCF ratio of 7.86.
| EV / Earnings | 108.37 |
| EV / Sales | 1.41 |
| EV / EBITDA | 13.44 |
| EV / EBIT | 22.30 |
| EV / FCF | 7.86 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.73 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | 1.39 |
| Interest Coverage | 4.15 |
Financial Efficiency
Return on equity (ROE) is 2.82% and return on invested capital (ROIC) is 4.47%.
| Return on Equity (ROE) | 2.82% |
| Return on Assets (ROA) | 2.68% |
| Return on Invested Capital (ROIC) | 4.47% |
| Return on Capital Employed (ROCE) | 6.16% |
| Weighted Average Cost of Capital (WACC) | 7.38% |
| Revenue Per Employee | 1.34M |
| Profits Per Employee | 17,346 |
| Employee Count | 7,462 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 4.63 |
Taxes
In the past 12 months, SHE:300244 has paid 144.51 million in taxes.
| Income Tax | 144.51M |
| Effective Tax Rate | 37.04% |
Stock Price Statistics
The stock price has increased by +30.97% in the last 52 weeks. The beta is 0.71, so SHE:300244's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +30.97% |
| 50-Day Moving Average | 18.73 |
| 200-Day Moving Average | 18.64 |
| Relative Strength Index (RSI) | 56.56 |
| Average Volume (20 Days) | 33,847,399 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300244 had revenue of CNY 9.98 billion and earned 129.43 million in profits. Earnings per share was 0.21.
| Revenue | 9.98B |
| Gross Profit | 2.87B |
| Operating Income | 628.93M |
| Pretax Income | 390.16M |
| Net Income | 129.43M |
| EBITDA | 886.73M |
| EBIT | 628.93M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 2.13 billion in cash and 2.47 billion in debt, with a net cash position of -345.00 million or -0.56 per share.
| Cash & Cash Equivalents | 2.13B |
| Total Debt | 2.47B |
| Net Cash | -345.00M |
| Net Cash Per Share | -0.56 |
| Equity (Book Value) | 8.66B |
| Book Value Per Share | 10.68 |
| Working Capital | 6.72B |
Cash Flow
In the last 12 months, operating cash flow was 2.03 billion and capital expenditures -250.18 million, giving a free cash flow of 1.78 billion.
| Operating Cash Flow | 2.03B |
| Capital Expenditures | -250.18M |
| Depreciation & Amortization | 257.79M |
| Net Borrowing | -934.89M |
| Free Cash Flow | 1.78B |
| FCF Per Share | 2.92 |
Margins
Gross margin is 28.80%, with operating and profit margins of 6.30% and 1.30%.
| Gross Margin | 28.80% |
| Operating Margin | 6.30% |
| Pretax Margin | 3.91% |
| Profit Margin | 1.30% |
| EBITDA Margin | 8.89% |
| EBIT Margin | 6.30% |
| FCF Margin | 17.88% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 1.85%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 1.85% |
| Dividend Growth (YoY) | -61.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 189.21% |
| Buyback Yield | 0.39% |
| Shareholder Yield | 2.25% |
| Earnings Yield | 1.12% |
| FCF Yield | 15.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:300244 is 18.84, which is -3.48% lower than the current price. The consensus rating is "Buy".
| Price Target | 18.84 |
| Price Target Difference | -3.48% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 3.10% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 9, 2016. It was a forward split with a ratio of 1.8.
| Last Split Date | May 9, 2016 |
| Split Type | Forward |
| Split Ratio | 1.8 |
Scores
SHE:300244 has an Altman Z-Score of 3.01 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.01 |
| Piotroski F-Score | 7 |